Infinera Corporation (INFN) ripping higher today with price breaking out to a fresh multi-year high over $13. Shares of the optical transport networking equipment provider are trading up nearly 27% following the company’s better than expected Q3 results and Q4 guidance. INFN is trading at an unusually high volume Thursday with 16 million shares changing hands. It is currently at more than 8x its 3-month average volume.
On valuation measures, Infinera has a PEG and forward P/E ratio of 2.04 and 34.41, respectively. Price/Sales for the same period is 2.23 while EPS is ($0.05). Currently there are 8 analysts that rate INFN a ‘Buy’, while 2 rate it a ‘Hold’. No analyst rates it a ‘Sell’. INFN has a median Wall Street price target of $13.50 with a high target of $16.00.
In the past 52 weeks, shares of Sunnyvale, California-based company have traded between a low of $6.96 and a high of $13.50 and are now at $13.49. Shares are down 8.61% year-over-year ; up 8.49% year-to-date.
ClearOne, Inc. (CLRO) is one of today’s top movers, up 17.60% to $8.82. The stock is printing a higher than average trading volume with the issue trading 111,198K shares, compared to the average volume of 10,360.
ClearOne, Inc. shares are currently priced at 17.28x this year’s forecasted earnings compared to the industry’s -36.96x earnings multiple. Ticker has a PEG and forward P/E ratio of 1.05 and 10.99, respectively. Price/Sales for the same period is 1.29 while EPS is $0.51. Currently CLRO has a median Wall Street price target of $11.75 with a high target of $11.75.
In the past 52 weeks, shares of Salt Lake City, Utah-based communications solutions company have traded between a low of $7.47 and a high of $14.30. Shares are down about 10% year-over-year and 14.48% year-to-date.
New issue Alibaba Group Holding Ltd (BABA) is pushing 3% higher. The stock began trading this morning at $92.92 to currently trade up $2.51 from the prior days close of $91.63. On an intraday basis it has gotten as low as $92.82 and as high as $94.47.
Alibaba’s shares have advanced 7.85% in the last 4 weeks. Over the past 5 trading sessions the stock has gained about 6%. Currently there are 9 analysts that rate BABA a ‘Buy’, while 2 rate it a ‘Hold’. No analyst rates it a ‘Sell’. BABA has a median Wall Street price target of $102.50 with a high target of $125.00.
Celator Pharmaceuticals, Inc. (CPXX) is trading at unusually high volume Thursday with 1.1M shares changing hands. It is currently at 50X its average daily volume and trading up 38% at $2.31 as of 2:01 p.m. ET. The company today announced the pricing of an underwritten public offering of 6,611,150 shares of common stock and warrants to purchase up to 661,115 shares of its common stock. The shares of common stock and warrants are being offered in units consisting of one share of common stock and a warrant to purchase 0.10 of a share of common stock at a price of $1.95 per unit. The gross proceeds to Celator from this offering are expected to be approximately $12.9 million.
CPXX currently prints a one year loss of about 57.00% and a year-to-date loss of around 47.08%.
Disclaimer: This page contains affiliate links. If you choose to make a purchase after clicking a link, we may receive a commission at no additional cost to you. Thank you for your support!